0001193125-24-147330.txt : 20240528 0001193125-24-147330.hdr.sgml : 20240528 20240524215204 ACCESSION NUMBER: 0001193125-24-147330 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240521 ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL PROPERTIES TRUST INC CENTRAL INDEX KEY: 0001287865 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32559 FILM NUMBER: 24986116 BUSINESS ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPT Operating Partnership, L.P. CENTRAL INDEX KEY: 0001524607 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-177186 FILM NUMBER: 24986117 BUSINESS ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 8-K 1 d843547d8k.htm 8-K 8-K
MEDICAL PROPERTIES TRUST INCfalse00012878650001524607ALAL 0001287865 2024-05-21 2024-05-21 0001287865 mpw:MptOperatingPartnershipLpMember 2024-05-21 2024-05-21
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
8-K
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 21, 2024
 
 
MEDICAL PROPERTIES TRUST, INC.
MPT OPERATING PARTNERSHIP, L.P.
(Exact Name of Registrant as Specified in Charter)
 
 
Commission File Number
001-32559
Commission File Number
333-177186
 
Maryland
Delaware
 
20-0191742
20-0242069
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
1000 Urban Center Drive, Suite 501
Birmingham,
AL
 
35242
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code
(205)
969-3755
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol
 
Name of each exchange
on which registered
Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.   MPW   The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 

Item 2.03.
Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance
Sheet Arrangement of a Registrant.
On May 21, 2024, affiliates of MPT Operating Partnership, L.P., a Delaware limited partnership and the operating partnership of Medical Properties Trust, Inc., a Maryland corporation (together, the “Company”), agreed to terms of a secured loan facility with a consortium of institutional investors that provides for a term loan in aggregate principal amount of approximately £631 million ($800 million) secured by a portfolio of 27 properties located in the United Kingdom currently leased to affiliates of Circle Health Holdings Limited, and completed the transaction on May 24, 2024.
The facility carries a fixed rate of 6.877% over its
10-year
term, excluding fees and expenses, and is payable interest-only (quarterly in advance) through the maturity date. The facility is secured by first priority mortgages or similar security instruments on the relevant properties, including assignments of rents and security over accounts, and is
non-recourse
to the Company.
The facility is subject to customary events of default, including, without limitation, payment defaults, insolvency-related events and defaults caused by a failure to perform obligations as provided under the loan documents or by breach of representations and warranties. The loan documents also contain customary financial and leasing covenants, cash management and reserve requirements, requirements regarding the management and maintenance of the properties and maintenance of insurance on the properties, transfer restrictions and limitations on the incurrence of debt and granting of liens. If an event of default shall occur and be continuing under the facility, the principal amount outstanding, together with all accrued and unpaid interest and other amounts owing in respect thereof, including a make-whole amount, may be declared immediately due and payable by the lenders.
The borrowers are required to pay certain fees and expenses to the secured lenders in connection with the facility, including an origination and arrangement fee, a servicing and management fee, a security agent fee, a cash management fee and an exit fee payable at maturity or upon prepayment. Outstanding amounts under the facility may be prepaid at any time prior to the maturity date, in whole or in part, subject to a minimum prepayment amount and the payment of a make-whole premium equal to the sum of outstanding interest payment due through the maturity date, plus an exit fee, as applicable.
The Company intends to use the net proceeds of the facility to repay outstanding debt, including the Company’s £105 million secured term loan maturing in December 2024, a portion of its unsecured British pound sterling term loan maturing in January 2025, and a portion of its revolving credit facility, as well as for other general corporate purposes.

SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrants have duly caused this report to be signed on their behalf by the undersigned hereunder duly authorized.
 
MEDICAL PROPERTIES TRUST, INC.
By:  
/s/ R. Steven Hamner
Name:   R. Steven Hamner
Title:   Executive Vice President and Chief Financial Officer
 
MPT OPERATING PARTNERSHIP, L.P.
By:  
/s/ R. Steven Hamner
Name:   R. Steven Hamner
Title:   Executive Vice President and Chief Financial Officer of the sole member of the general partner of MPT Operating Partnership, L.P.
Date: May 28, 2024
EX-101.SCH 2 mpw-20240521.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 3 mpw-20240521_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 4 mpw-20240521_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 mpw-20240521_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 6 mpw-20240521_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover Page
May 21, 2024
Document Information [Line Items]  
Entity Registrant Name MEDICAL PROPERTIES TRUST INC
Amendment Flag false
Entity Central Index Key 0001287865
Document Type 8-K
Document Period End Date May 21, 2024
Entity File Number 001-32559
Entity Incorporation State Country Code MD
Entity Tax Identification Number 20-0191742
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.
Trading Symbol MPW
Security Exchange Name NYSE
Entity Emerging Growth Company false
MPT Operating Partnership LP [Member]  
Document Information [Line Items]  
Entity Registrant Name MPT OPERATING PARTNERSHIP, L.P.
Entity Central Index Key 0001524607
Entity File Number 333-177186
Entity Incorporation State Country Code DE
Entity Tax Identification Number 20-0242069
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 2 23 1 false 1 0 false 0 false false R1.htm 1001 - Document - Cover Page Sheet http://www.medicalpropertiestrust.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince, dei:EntityRegistrantName - d843547d8k.htm 7 d843547d8k.htm mpw-20240521.xsd mpw-20240521_cal.xml mpw-20240521_def.xml mpw-20240521_lab.xml mpw-20240521_pre.xml http://xbrl.sec.gov/dei/2023 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d843547d8k.htm": { "nsprefix": "mpw", "nsuri": "http://www.medicalpropertiestrust.com/20240521", "dts": { "inline": { "local": [ "d843547d8k.htm" ] }, "schema": { "local": [ "mpw-20240521.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "mpw-20240521_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20240521_def.xml" ] }, "labelLink": { "local": [ "mpw-20240521_lab.xml" ] }, "presentationLink": { "local": [ "mpw-20240521_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 1, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 36 }, "report": { "R1": { "role": "http://www.medicalpropertiestrust.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P05_21_2024To05_21_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d843547d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P05_21_2024To05_21_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d843547d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mpw_MptOperatingPartnershipLpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medicalpropertiestrust.com/20240521", "localname": "MptOperatingPartnershipLpMember", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "MPT Operating Partnership LP [Member]", "documentation": "MPT Operating Partnership LP." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001193125-24-147330-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-147330-xbrl.zip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end XML 19 d843547d8k_htm.xml IDEA: XBRL DOCUMENT 0001287865 2024-05-21 2024-05-21 0001287865 mpw:MptOperatingPartnershipLpMember 2024-05-21 2024-05-21 MEDICAL PROPERTIES TRUST INC false 0001287865 0001524607 AL AL 8-K 2024-05-21 MPT OPERATING PARTNERSHIP, L.P. 001-32559 333-177186 MD DE 20-0191742 20-0242069 1000 Urban Center Drive 1000 Urban Center Drive Suite 501 Suite 501 Birmingham Birmingham 35242 35242 205 205 969-3755 969-3755 false false false false Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc. MPW NYSE false false